March 11, 2025 Tags: semaglutide, GLP-1, medical weight loss Many people struggle with weight loss, and with warmer weather and tank tops ahead, now is a prominent time for people seeking to achieve their dream body
However, the drug is not to be used if: You or any of your family has ever had medullary thyroid carcinoma (MTC) You have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) You are allergic to semaglutide or any of the inactive ingredients When taking compounded semaglutide, ask the compounding pharmacy for the inactive ingredients to avoid severe allergic reactions
The STEP trials (Semaglutide Treatment Effect in People with obesity) demonstrated that semaglutide users lost an average of 15% to 22% of body weight over 68 weeks when combined with lifestyle modifications
Theres also the issue of distrust and reduced help-seeking some minority communities may be less likely to seek psychiatric care early, leading to more severe presentations when they do get care
However, no information system can be 100% secure
The Emerging Role of Glucagon-like Peptide-1 Receptor Agonists for the Management of NAFLD